NewGenIvf Group Ltd Reports 9-Month 2025 Results
Ticker: NIVFW · Form: 6-K · Filed: Dec 2, 2025 · CIK: 1981662
| Field | Detail |
|---|---|
| Company | Newgenivf Group LTD (NIVFW) |
| Form Type | 6-K |
| Filed Date | Dec 2, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: results, foreign-private-issuer, financial-reporting
TL;DR
NewGenIvf (NGIV) dropped its 9-month 2025 results on 12/2/25. Check Exhibit 99.1 for details.
AI Summary
NewGenIvf Group Limited filed a Form 6-K on December 2, 2025, reporting its nine-month results for 2025. The company, formerly known as ASPAC I Mini Acquisition Corp., is based in Bangkok, Thailand, and is a foreign private issuer. The filing includes Exhibit 99.1, which details the company's financial performance for the first nine months of 2025.
Why It Matters
This filing provides investors with an update on NewGenIvf Group's financial performance for the first nine months of 2025, offering insights into the company's operational results and financial health.
Risk Assessment
Risk Level: low — This is a routine filing reporting financial results, with no immediate indication of significant new risks or material adverse events.
Key Numbers
- Nine-Month 2025 — Reporting Period (Results for the first nine months of 2025 are detailed in Exhibit 99.1.)
Key Players & Entities
- NewGenIvf Group Limited (company) — Registrant
- ASPAC I Mini Acquisition Corp. (company) — Former company name
- December 2, 2025 (date) — Filing date and reporting period
- Wing Fung Alfred Siu Nam (person) — Signatory for the company
FAQ
What specific financial metrics are reported in Exhibit 99.1 for the nine-month period of 2025?
The filing itself does not detail the specific financial metrics within Exhibit 99.1, only that it contains the 'NewGen Reports Nine-Month 2025 Results'.
When was NewGenIvf Group Limited previously known by another name?
NewGenIvf Group Limited was formerly known as ASPAC I Mini Acquisition Corp., with a date of name change on June 14, 2023.
Where is NewGenIvf Group Limited's principal executive office located?
The principal executive offices are located at 36/39-36/40, 13th Floor, PS Tower Sukhumvit 21 Road (Asoke), Khlong Toei Nuea Sub-district, Watthana District, Bangkok 10110, Thailand.
What is the filing type and purpose of this document?
This is a Form 6-K, a Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 Under the Securities Exchange Act of 1934, for the month of December 2025.
Who signed this Form 6-K on behalf of NewGenIvf Group Limited?
The report was signed by /s/ Wing Fung Alfred Siu Nam, pursuant to the requirements of the Securities Exchange Act of 1934.
Filing Stats: 162 words · 1 min read · ~1 pages · Grade level 12.9 · Accepted 2025-12-02 08:01:34
Filing Documents
- ea0268067-6k_newgen.htm (6-K) — 9KB
- ea026806701ex99-1_newgen.htm (EX-99.1) — 79KB
- 0001213900-25-116959.txt ( ) — 89KB
From the Filing
OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2025 Commission File Number: 001-42004 NEWGENIVF GROUP LIMITED 36/39-36/40, 13th Floor, PS Tower Sukhumvit 21 Road (Asoke) Khlong Toei Nuea Sub-district Watthana District, Bangkok 10110 Thailand (Address of Principal Executive Offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F EXHBIT INDEX Exhibit No. Description 99.1 NewGen Reports Nine-Month 2025 Results 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: December 2, 2025 NewGenIvf Group Limited By: /s/ Wing Fung Alfred Siu Name: Wing Fung Alfred Siu Title: Chairman of the Board and Director 2